Article
PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.
Journal of cellular physiology - 1 Apr 2021
Ma Hanlin, Han Fang, Yan Xiaohui, Qi Gonghua, Li Yingwei, Li Rongrong, Yan Shi, Yuan Cunzhong, Song Kun, Kong Beihua
Abstract excerpt
Cervical cancer is the fourth most frequent cancer in women worldwide. PDZ-binding kinase (PBK) is proven to promote the malignant behaviors of various carcinomas. However, its functional roles and oncogenic mechanisms in cervical cancer are poorly understood. In this study, we reported that PBK was highly expressed in cervical cancer tissues. PBK promoted the proliferation, metastasis, and cisplatin resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
